Usefulness of lanoconazole (Astat®) cream in the treatment of hyperkeratotic type tinea pedis. Comparative study of monotherapy and combination therapy with 10% urea ointment (Pastaron®)

Mycoses

Volumn 44, Issue 5-6, 2001, Pages 181-190

  Tanuma, H ^a   Tanuma, M ^a   Abe, M ^b   Kume, H ^c  

^a Tanuma Dermalological Clinic   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antimycotic chemotherapy; Combination therapy; Hyperkeratosis; Lanoconazole; Tinea pedis; Urea ointment

Indexed keywords

GRISEOFULVIN; LANOCONAZOLE; PASTARON; UREA;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DERMATOMYCOSIS; DRUG EFFICACY; FEMALE; HUMAN; HYPERKERATOSIS; MALE; MONOTHERAPY; OINTMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TINEA PEDIS;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; IMIDAZOLES; KERATOSIS; MALE; MIDDLE AGED; OINTMENTS; RETROSPECTIVE STUDIES; TIME FACTORS; TINEA PEDIS; TREATMENT OUTCOME; UREA;

TINEA;

EID: 0034947959     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0933-7407.2001.00607.x     Document Type: Article

References (24)

1. Tanuma, H. (1995) Treatment of hyperkeratotic type tinea pedis. Risho derma. (Tokyo) 37, 1939-1946.
2. Tanuma, H. (1999) Pathogenesis and Treatment of hyperkeratotic tinea pedis in Japan. Mycoses 42, 21-28.
3. Greer, D. (1987) Topical treatment for moccasin-type tinea pedis. J. Am. Acad. Dermatol. 16, 554-558.
4. Savin, R. C. & Zaias, N. (1990) Treatment of chronic moccasin type tinea pedis with terbinafine. A double-blind, Placebo-controlled trial. J. Am. Acad. Dermatol. 23, 807-809.
5. Savin, R. C., Atton, A. V., Bergstresser, P. R., Elewski, B., Jones, H. E. & Levine, N. (1994) Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: Result of placebo controlled multicenter trials. J. Am. Acad. Dermatol. 30, 663-667.
6. Tanuma, H. & Nishiyama, S. (1997) Clinical evaluation of bifonazole for moccasin-type tinea pedis. Mycoses 40, 223-228.
7. Tanuma, H., Doi, M., Yaguchi, A. et al. (1998) Efficacy of oral fluconazole in tinea pedis of the hyperkeratotic type. Stratum corneum levels. Mycoses 40, 153-116.
8. Tanuma, H., Doi, M., Ohta, Y., Nishiyama, S., Katsuoka, K., Kaneko, S., Mukai, H. & Abe, M. (2000) Usefulness of 1% Terbinafine HCL (Lamisil®) cream for hyperkeratotic-type tinea pedis and its transfer into the horny layers. Mycoses 43, 579-593.
9. Tanuma, H., Doi, M., Sato, N., Nishiyama, S., Abe, M., Kume, H. & Katsuoka, K. (2000) Usefulness of Bifonazole (Mycospor®) cream for the treatment of moccasin-type tinea pedis. Mycoses 43, 129-137.
10. Hiratani, T., Uchida, K., Yamaguchi, H. et al. (1992) In Vitro antifungal activity of NND-318, a new Antimycotic. Jpn J. Med. Mycol. 33, 321-328.
11. Uchida, K., Aoki, K. & Yamaguchi, H. (1992) In Vitro antifungal activity of NND-318, a new Imidazole Antimycotic, against clinical isolates from patients with cutaneous mycosis. Jpn J. Med. Mycol. 33, 361-366.
12. Takahashi, H. (1992) TJN-318 (NNDD-318): Evaluation of antifungal activities, result of clinical open study on dermatomycosis. In: Yamaguchi, H., Kobayashi, G. S. & Takahashi, H. (eds) Recent Progress in Antifungal Chemotherapy. New York: Mancel Dekker, pp. 103-112.
13. Ohmi, T., Konaka, S., Uchida, M. et al. (1992) NND-318, a new antifungal imidazole, its in vitro and in vivo activity against pathogenic fungi of dermatomycosis. In: Yamaguchi, H., Kobayashi. G. S. & Takahashi, H. (eds) Recent Progress in Antifungal Chemotherapy). New York: Mancel Dekker, pp. 461-464.
14. Ohmi, T., Konaka, M., Uchida, M. et at. (1991) Antifungal activity of the new agent lanoconazole in two tinea model. Azneim.-Forsch/Drug Res. 41, 847-851.
15. Niwano, Y., Tabuchi, T., Kanai, K. et al. (1994) Therapeutic efficacy of Lanoconazole ointment in guinea pig model of tinea pedis, in comparison with that of cream preparations. Jpn J. Antibiot 47, 1192-1195.
16. Niwano, Y., Tabuchi, T., Kanai, K. et al. (1995) Therapeutic efficacy of lanoconazole ointment in guinea pig model of tinea corporis, a comparative study with ointment and cream preparations. Jpn J. Antibiot 48, 150-154.
17. Oka, H., Niwano, Y., Ohmi, Y. et al. (1992) Therapeutic efficacy of lanoconazole in formulation of clinical use of experimental dermatophytosis in guinea pigs. Arzneim.-Forsch/Drug Res. 42, 345-349.
18. TJN-318 Cream Study Group. (1992) Early Phase II Study of TJN-318 cream on the patients with dermatomycosis. Nishinihon J. Dermatol. 54, 954-961.
19. TJN-318 Cream Study Group. (1992) Optimum application dose establishing double-blind study on the patients with dermatomycosis. Nishinihon J. Dermatol. 54, 962-976.
20. TJN-318 Cream Study Group. (1992) Double-blind comparative study of TJN-318 cream and bifonazole cream on the patients with dermatomycosis. Nishinihon J. Dermatol. 54, 977-992.
21. TJN-318 Solution Study Group. (1992) Phase II Study of TJN-318 Solution on the patients of dermatomycosis. Nishinihon J. Dermatol. 54, 944-953.
22. Takahashi, H., Saito, S., Tanuma, H. et al. (1993) Studies on the efficacy and safety of lanoconazole in the patient of hyperkeratotic type tinea pedis. Nishinihon J. Dermatol. 55, 961-971.
23. Sadakane, C. & Yamamoto, K. (1996) Parmacokinetic study following topical application of Astat® cream in tinea pedis patients to evaluate retentivity of lanconazole (LCZ) in the horny layer. Clin. Report 30, 2319-2326.
24. Niwano, Y., Matsui, M., Tabuchi, T. et al. (1997) Studies on the Antifungal Activity of the New Imidazole Antimycotic Lanoconazole in vitro activity in the presence of stratum corneum. Azmeim.-Forsh/Drug Res. 4, 1056-1060.